Match tier Confirmed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-06

Phillip F. Pierce

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

Faculty Researcher

24 h-index 58 pubs 2,097 cited

  • Humans
  • Male
  • Adult
  • Female
  • Middle Aged
  • HIV-1
  • Treatment Outcome
  • Acquired Immunodeficiency Syndrome
  • Fluoroquinolones
  • Recurrence
  • HIV Seropositivity
  • Enzyme-Linked Immunosorbent Assay
  • Gatifloxacin
  • Child, Preschool
  • Infant

Biography and Research Information

OverviewAI-generated summary

Phillip F. Pierce is a faculty member at Arkansas State University with a research focus on the efficacy and safety of pharmacological interventions for neuropathic pain, particularly diabetic peripheral neuropathic pain (DPNP). His recent work includes studies on LX9211, an orally-administered, non-opioid inhibitor of AAK1, investigating its potential for relieving DPNP. Pierce has also been involved in research exploring pilavapadin, another oral, non-opioid AAK1 inhibitor for DPNP, through Phase 2b dose-ranging studies.

Beyond pain management, Pierce's research extends to the development and validation of mobile health applications. He has contributed to reliability studies for SOBER-EYE, a phone application designed to assess pupillary light reflex. His scholarly output includes 58 publications with over 2,000 citations, and he holds an h-index of 24. He collaborates with colleagues such as S. L. Bruce on shared publications and maintains an active laboratory website.

Metrics

  • h-index: 24
  • Publications: 58
  • Citations: 2,097

Selected Publications

  • A Reliability Study for SOBER-EYE, A Pupillary Light Reflex Assessment Phone App (2025)

View all publications on OpenAlex →

Collaboration Network

2 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics